InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
1.690
0.00 (0.00%)
Jul 29, 2026, 11:05 AM EDT - Market open
InflaRx Market Cap
InflaRx has a market cap or net worth of $248.92 million as of July 29, 2026. Its market cap has increased by 319.01% in one year.
Market Cap
248.92M
Enterprise Value
203.98M
1-Year Change
319.01%
Ranking
Category
Stock Price
$1.69
ChartMarket Cap Chart
Since November 8, 2017, InflaRx's market cap has decreased from $351.36M to $248.92M, a decrease of -29.15%. That is a compound annual growth rate of -3.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 248.92M | 263.79% |
| Dec 31, 2025 | 68.42M | -52.95% |
| Dec 31, 2024 | 145.44M | 51.53% |
| Dec 29, 2023 | 95.98M | -29.96% |
| Dec 30, 2022 | 137.03M | -34.85% |
| Dec 31, 2021 | 210.33M | 48.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ALX Oncology Holdings | 267.78M |
| Lineage Cell Therapeutics | 266.75M |
| Q32 Bio | 266.39M |
| SAB Biotherapeutics | 263.80M |
| Eledon Pharmaceuticals | 262.83M |
| Niagen Bioscience | 262.58M |
| ProQR Therapeutics | 248.37M |
| Fulcrum Therapeutics | 247.88M |